These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
387 related items for PubMed ID: 18931957
21. A Greek family with a follicular variant of familial papillary thyroid carcinoma: TCO, MNG1, fPTC/PRN, and NMTC1 excluded as susceptibility loci. Tsilchorozidou T, Vafiadou E, Yovos JG, Romeo G, McKay J, Lesueur F, Bonora E. Thyroid; 2005 Dec; 15(12):1349-54. PubMed ID: 16405407 [Abstract] [Full Text] [Related]
22. Familial non-medullary thyroid carcinoma displays the features of clinical anticipation suggestive of a distinct biological entity. Capezzone M, Marchisotta S, Cantara S, Busonero G, Brilli L, Pazaitou-Panayiotou K, Carli AF, Caruso G, Toti P, Capitani S, Pammolli A, Pacini F. Endocr Relat Cancer; 2008 Dec; 15(4):1075-81. PubMed ID: 18832444 [Abstract] [Full Text] [Related]
23. [Hereditary thyroid carcinoma and its molecular diagnostics]. Dvořáková S, Václavíková E, Sýkorová V, Hálková T, Bendlová B. Cesk Patol; 2014 Apr; 50(2):81-6. PubMed ID: 24758503 [Abstract] [Full Text] [Related]
24. Familial history of non-medullary thyroid cancer is an independent prognostic factor for tumor recurrence in younger patients with conventional papillary thyroid carcinoma. Lee YM, Yoon JH, Yi O, Sung TY, Chung KW, Kim WB, Hong SJ. J Surg Oncol; 2014 Feb; 109(2):168-73. PubMed ID: 24132694 [Abstract] [Full Text] [Related]
25. Inherited Follicular Epithelial-Derived Thyroid Carcinomas: From Molecular Biology to Histological Correlates. Cameselle-Teijeiro JM, Mete O, Asa SL, LiVolsi V. Endocr Pathol; 2021 Mar; 32(1):77-101. PubMed ID: 33495912 [Abstract] [Full Text] [Related]
28. Whole exome and target sequencing identifies MAP2K5 as novel susceptibility gene for familial non-medullary thyroid carcinoma. Ye F, Gao H, Xiao L, Zuo Z, Liu Y, Zhao Q, Chen H, Feng W, Fu B, Sun L, Jiang X, He D, Jiang H, Yang M, Li L, Chen F, Liu X, Li S, Li Z, Jiang Y, Cheng L, Bu H. Int J Cancer; 2019 Mar 15; 144(6):1321-1330. PubMed ID: 30132833 [Abstract] [Full Text] [Related]
33. Medullary carcinoma of the thyroid: differentiating the types and current management. Samaan NA, Hickey RC. Oncology (Williston Park); 1987 Dec 26; 1(10):21-8. PubMed ID: 2908613 [Abstract] [Full Text] [Related]
34. Familial non-medullary thyroid carcinoma (FNMTC): analysis of fPTC/PRN, NMTC1, MNG1 and TCO susceptibility loci and identification of somatic BRAF and RAS mutations. Cavaco BM, Batista PF, Martins C, Banito A, do Rosário F, Limbert E, Sobrinho LG, Leite V. Endocr Relat Cancer; 2008 Mar 26; 15(1):207-15. PubMed ID: 18310288 [Abstract] [Full Text] [Related]